期刊文献+

胰淀素对格列苯脲刺激INS-1细胞胰岛素分泌作用的影响及其机制 被引量:2

The effects and mechanism of islet amyloid polypeptide on insulin secretion in INS-1 cells stimulated by glibenclamide
原文传递
导出
摘要 目的 研究胰淀素短时间条件下对格列苯脲刺激INS-1细胞胰岛素分泌的影响及机制.方法 分别采用全细胞膜片钳技术、激光共聚焦显微镜技术及ELISA分析不同浓度胰淀素短时间孵育前后格列苯脲刺激下INS-1细胞ATP敏感性钾通道(KATP通道)电生理学特性、细胞内钙离子浓度([Ca2+]i)及胰岛素含量变化.结果 (1) ELISA结果显示:与1μmol/L格列苯脲刺激下胰岛素释放量(11.43 ±1.22) μg/L比较,0.1μmol/L胰淀素预处理组[(11.45 ±1.20) μg/L]无明显差异,而1 μmol/L及10 μmol/L胰淀素预处理组均显著下降,分别为(9.40±0.87)μg/L和(7.11±0.85) μg/L,且呈剂量相关性(P<0.05);(2)激光共聚焦显微镜测钙结果显示:1μmol/L格列苯脲刺激后[Ca2+]i荧光强度变化的AUC为427.78±2.32,0.1μmol/L胰淀素预处理组(424.09 ±2.21)与之差异无统计学意义;而1 μmol/L及10 μmol/L胰淀素预处理组均可使其AUC显著降低(分别为380.59 ±1.49和246.53±8.41),并呈剂量相关性(P<0.05);(3)全细胞膜片钳结果显示:在1μmol/L、10 μmol/L胰淀素预处理组中,1μmol/L格列苯脲刺激下KATP通道半数激活电压(V0.5)分别为(28.75 ±0.77)mV和(46.95 ±1.81)mV,均显著高于单纯格列苯脲组(14.59±0.69)mV,并呈剂量相关性(P<0.05).结论 高浓度胰淀素短时间作用可抑制格列苯脲对KATP通道的关闭,进而抑制[Ca2+]i增加,推测这种作用是INS-1细胞胰岛素分泌减少的机制之一. Objective To observe the effects,and study the mechanism of islet amyloid polypeptide (IAPP) on insulin secretion in INS-1 cells stimulated by glibenclamide.Methods Whole cell patch clamp technique was employed to study the influences of short exposure to IAPP on electrophysiological characteristics of ATP-sensitive K+ channel(KATP channel) upon sulfonylurea stimulation.Intracellular free calcium changes in this process was observed by laser scanning confocal microscope.Insulin was measured by enzyme-linked immunoassay.Results (1)Insulin secretion stimulated by 1 μmol/L glibenclamide was significantly decreased from (11.43 ± 1.22) μg/L to (9.40 ± 0.87) μg/L and to (7.11 ± 1.85) μg/L after 1 μmol/L and 10 μmol/L IAPP incubation,respectively.(2)Glibenclamide-stimulated calcium influx was dose dependently inhibited by IAPP from 1 μmol/L to 10 μmol/L,with the AUC of fluorescence intensity-time reduced from 427.78 ± 2.32 to 380.59 ± 1.49,and to 246.53 ± 8.41,respectively.(3) Compared with that in control cells (14.59 ± 0.69) mV,the half activation voltage of KATP channel in response to glibenclamide was significantly increased to (28.75 ±0.77) mV and to (46.95 ± 1.81) mV in cells pretreated with 1 μmol/L and 10 μmol/L IAPP,implicating an inhibitory effect of IAPP on activation of KATP channel.Conclusion Short-term exposure to high concentration of IAPP inhibited glibenclamideinduced closure of KATP,channels and decreased calcium influx,which may ultimately lead to the reduction of insulin secretion in INS-1 cells.
出处 《中华内科杂志》 CAS CSCD 北大核心 2015年第3期214-218,共5页 Chinese Journal of Internal Medicine
基金 国家自然科学基金(81241030) 天津市应用基础与前沿技术研究计划(14JcYBJc24600)
关键词 胰淀素 INS-1细胞 格列苯脲 胰岛素 Islet amyloid polypeptide INS-1 cells Glibenclamide Insulin
  • 相关文献

参考文献12

  • 1Xu Y, Wang L, He J, et al. Prevalence and control of diabetes in Chinese adults[J]. JAMA, 2013, 310(9):948-959.
  • 2无,童南伟.中国成人2型糖尿病胰岛素促泌剂应用的专家共识[J].中华内分泌代谢杂志,2012,28(4):261-265. 被引量:41
  • 3朱铁虹,尹潍,张卫华,高淑伟,畅继武.胰淀素对优降糖刺激大鼠胰岛素分泌作用的影响及其机制[J].中华内科杂志,1999,38(4):248-250. 被引量:16
  • 4朱铁虹,尹潍,高淑伟.磺脲类降糖药继发性失效的2型糖尿病患者血浆胰淀素水平[J].中华内分泌代谢杂志,2003,19(1):29-30. 被引量:14
  • 5Proks P, Reimann F, Green N, et al. Sulfonylurea stimulation of insulin secretion[J]. Diabetes, 2002, 51( Suppl 3): S368-376.
  • 6Soty M, Visa M, Soriano S, et al. Involvement of ATP-sensitive potassium (K(ATP)) channels in the loss of beta-cell function induced by human islet amyloid polypeptide[J]. J Biol Chem, 2011, 286(47): 40857-40866.
  • 7Westermark P, Andersson A, Westermark GT. Islet amyloid polypeptide, islet amyloid, and diabetes mellitus[J].Physiol Rev, 2011, 91(3):795-826.
  • 8German MS, Moss LG, Wang J, et al. The insulin and islet amyloid polypeptide genes contain similar cell-specific promoter elements that bind identical beta-cell nuclear complexes[J].Mol Cell Biol, 1992, 12(4):1777-1788.
  • 9Lomasney AR, Yi L, Roper MG. Simultaneous monitoring of insulin and islet amyloid polypeptide secretion from islets of Langerhans on a microfluidic device[J]. Anal Chem, 2013, 85(16):7919-7925.
  • 10Rachman J, Payne MJ, Levy JC, et al. Changes in amylin and amylin-like peptide concentrations and beta-cell function in response to sulfonylurea or insulin therapy in NIDDM[J].Diabetes Care, 1998, 21(5):810-816.

二级参考文献17

  • 1杨文英.磺脲类药物应用专家共识[J].国外医学(内分泌学分册),2004,24(4):255-259. 被引量:75
  • 2何戎华.磺脲类降糖药治疗失效研究进展[J].国外医学(内分泌学分册),1995,15(2):81-83. 被引量:10
  • 3贾伟平,陆俊茜,高鑫,邢惠莉,刘伟,刘志民,盛正妍,胡仁明,宁光,邹大进,冯波,项坤三.新诊断2型糖尿病患者一相胰岛素分泌和胰岛素敏感性评估[J].中华内分泌代谢杂志,2007,23(2):100-103. 被引量:32
  • 4黄丹珊.胰淀素对磺脲类口服降糖药的抑制效应.全国首届内分泌专业中青年论文交流会汇编[M].北京:-,1994.194-196.
  • 5向红丁.磺脉类降糖药对HIT细胞胰岛素分泌刺激作用的分子机制研究[J].中国糖尿病杂志,1994,2:34-37.
  • 6何戎华,国外医学.内分泌学分册,1995年,15卷,81页
  • 7黄丹珊,全国首届内分泌专业中青年论文交流会汇编,1994年,194页
  • 8向红丁,中国糖尿病杂志,1994年,2卷,34页
  • 9钱玉宁,中国糖尿病杂志,1993年,1卷,21页
  • 10A. Lukinius,E. Wilander,G. T. Westermark,U. Engstr?m,P. Westermark. Co-localization of islet amyloid polypeptide and insulin in the B cell secretory granules of the human pancreatic islets[J] 1989,Diabetologia(4):240~244

共引文献64

同被引文献23

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部